Projected Income Statement: Celanese Corporation

Forecast Balance Sheet: Celanese Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 2,768 3,431 13,171 11,879 11,617 11,457 10,497 9,492
Change - 23.95% 283.88% -9.81% -2.21% -1.38% -8.38% -9.57%
Announcement Date 1/28/21 1/27/22 2/23/23 2/20/24 2/18/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Celanese Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 364 467 543 568 435 329.6 372 416.5
Change - 28.3% 16.27% 4.6% -23.42% -24.24% 12.88% 11.96%
Free Cash Flow (FCF) 1 979 1,290 1,276 1,320 498 761.6 758.5 959.1
Change - 31.77% -1.09% 3.45% -62.27% 52.93% -0.4% 26.44%
Announcement Date 1/28/21 1/27/22 2/23/23 2/20/24 2/18/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Celanese Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 26.08% 33.21% 27.05% 22.34% 23.11% 19.99% 21.19% 21.76%
EBIT Margin (%) 20% 28.97% 22.44% 16.02% 16.03% 12.34% 14% 14.71%
EBT Margin (%) 39.81% 26.33% 14.69% 10.81% -9.69% -11.76% 6.93% 8.34%
Net margin (%) 35.1% 22.14% 19.58% 17.92% -14.81% -11.24% 5.96% 6.89%
FCF margin (%) 17.31% 15.11% 13.19% 12.07% 4.84% 7.95% 7.88% 9.63%
FCF / Net Income (%) 49.32% 68.25% 67.37% 67.35% -32.72% -70.76% 132.18% 139.78%

Profitability

        
ROA 19.48% 16.52% 9.07% 3.69% 3.7% -0.24% 2.7% 3.46%
ROE 30% 52.65% 35.29% 15.34% 14.92% 9.72% 12.96% 14.63%

Financial Health

        
Leverage (Debt/EBITDA) 1.88x 1.21x 5.03x 4.86x 4.89x 5.98x 5.14x 4.38x
Debt / Free cash flow 2.83x 2.66x 10.32x 9x 23.33x 15.04x 13.84x 9.9x

Capital Intensity

        
CAPEX / Current Assets (%) 6.44% 5.47% 5.61% 5.19% 4.23% 3.44% 3.86% 4.18%
CAPEX / EBITDA (%) 24.68% 16.47% 20.75% 23.24% 18.31% 17.21% 18.23% 19.22%
CAPEX / FCF (%) 37.18% 36.2% 42.55% 43.03% 87.35% 43.27% 49.04% 43.43%

Items per share

        
Cash flow per share 1 11.33 15.67 16.66 17.36 8.838 9.262 9.839 11.8
Change - 38.3% 6.28% 4.21% -49.08% 4.8% 6.24% 19.95%
Dividend per Share 1 2.48 2.72 2.74 2.8 2.8 0.1225 0.1299 0.1233
Change - 9.68% 0.74% 2.19% 0% -95.63% 6.09% -5.07%
Book Value Per Share 1 29.93 38.78 51.97 64.82 47.35 42 48.04 53.84
Change - 29.55% 34.01% 24.73% -26.95% -11.28% 14.36% 12.07%
EPS 1 16.75 16.86 17.34 17.92 -13.93 -9.788 5.248 6.242
Change - 0.66% 2.85% 3.34% -177.73% 29.74% 153.62% 18.93%
Nbr of stocks (in thousands) 116,895 108,871 108,428 108,855 109,312 109,505 109,505 109,505
Announcement Date 1/28/21 1/27/22 2/23/23 2/20/24 2/18/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio -3.98x 7.42x
PBR 0.93x 0.81x
EV / Sales 1.64x 1.53x
Yield 0.31% 0.33%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
38.94USD
Average target price
52.50USD
Spread / Average Target
+34.82%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. CE Stock
  4. Financials Celanese Corporation